Prostatic Artery Embolization: A Practical Option for Men on Testosterone Therapy With Prostate Symptoms

Testosterone therapy can be an important part of care for men diagnosed with testosterone deficiency. But if a man receiving testosterone replacement therapy (TRT) begins waking repeatedly at night to urinate, notices a weaker stream, feels urgency, or has trouble emptying his bladder, those changes deserve attention. These symptoms are known as lower urinary tract symptoms (LUTS) and can be associated with benign prostatic hyperplasia (BPH), or an enlarged prostate.

For some men, the concern is not simply urinary comfort. It is the need to address bothersome prostate symptoms without losing sight of the sexual health, energy, and quality-of-life goals that led them to consider TRT in the first place. Prostatic artery embolization (PAE) may be a practical treatment option to discuss when BPH-related symptoms are affecting daily life.

At Vascular and Interventional Specialists of Orange County, we offer a minimally invasive approach to enlarged-prostate symptoms through PAE. The procedure does not treat low testosterone, and it does not replace appropriate TRT monitoring. Rather, it is designed to address the prostate-related obstruction that may be contributing to urinary symptoms.

Testosterone Therapy and Prostate Symptoms: Avoid Assumptions

It is understandable to connect new urinary symptoms with testosterone therapy. Testosterone and prostate biology are related, but the clinical relationship is more nuanced than the old assumption that TRT automatically causes significant prostate enlargement or worsening urinary symptoms. Available clinical evidence has not consistently shown that TRT worsens LUTS, although the evidence has limitations and symptoms should always be assessed in the context of the individual patient.

That distinction matters. A weak stream or frequent nighttime urination is not a diagnosis by itself, and it should not prompt someone to change or stop prescribed testosterone on their own. LUTS can have several possible causes, including BPH, bladder conditions, infection, medication effects, or other urologic concerns. Coordinated evaluation with the TRT-prescribing clinician and a qualified prostate-care team can help identify the right next step. The Endocrine Society also emphasizes appropriate patient selection and ongoing monitoring for men receiving testosterone therapy.

What Is Prostatic Artery Embolization (PAE)?

PAE is a catheter-based, image-guided treatment for symptoms caused by an enlarged prostate. An interventional radiologist accesses an artery through a very small puncture in the wrist or groin, guides a microcatheter to the arteries supplying the prostate, and delivers tiny embolic particles. Reducing this targeted blood supply causes the enlarged prostate tissue to shrink gradually, relieving pressure on the urethra over time.

Unlike procedures performed through the urethra, PAE does not involve cutting out prostate tissue. It is typically performed on an outpatient basis, often using local anesthesia and sedation rather than general anesthesia. Individual treatment plans, access sites, and recovery experiences vary, but the objective is consistent: meaningful symptom relief through a minimally invasive approach.

Why PAE May Be a Practical Conversation for Men on TRT

Men on testosterone therapy are not a separate category of PAE candidate simply because they use TRT. However, the priorities that often accompany TRT—sexual well-being, energy, physical activity, and avoiding a prolonged recovery—can make a minimally invasive BPH discussion especially relevant.

The Society of Interventional Radiology’s multisociety position statement identifies men who want to preserve sexual function among the patient groups for whom PAE may be particularly suitable when appropriately selected. That does not mean that PAE guarantees preservation of erectile or ejaculatory function, or that it is automatically the preferred procedure for every patient. It means sexual-function goals should be explicitly included in the decision-making conversation.

The evidence also supports a balanced view of treatment effectiveness. A systematic review and meta-analysis of randomized trials found that, at 12 months, PAE and transurethral resection of the prostate (TURP) had no significant difference in patient-reported symptom scores or quality-of-life outcomes. In that analysis, PAE was associated with fewer complications and shorter hospitalization, while TURP produced greater improvement in many objective functional measures. A five-year randomized study similarly found that PAE can provide durable improvement for properly selected patients, but that TURP achieved greater improvements in some symptoms and objective measures.

The practical takeaway: PAE is not a substitute for a full BPH evaluation, and it is not “better” than every surgical approach. It is a well-established, minimally invasive option that may fit the goals and anatomy of some men receiving TRT who are dealing with BPH-related urinary symptoms.

PAE, Medication, and TURP: Framing the Conversation

Choosing a treatment is not only about a prostate measurement or symptom score. It is also about medical history, the degree of obstruction, symptom severity, medication tolerance, recovery preferences, sexual-function priorities, and the possibility that a future procedure could be needed.

What a Thoughtful PAE Evaluation Should Include

A responsible PAE consultation begins with an accurate diagnosis. At Vascular and Interventional Specialists of Orange County, the conversation should focus on how symptoms affect a patient’s life, whether BPH is likely to be the cause, and whether arterial anatomy and overall health support PAE as a reasonable treatment path.

For men receiving testosterone therapy, it is particularly helpful for the PAE team, urologist when involved, and TRT-prescribing clinician to have a shared picture of current symptoms, prostate screening and monitoring, medications, and treatment goals. That coordination helps avoid a false choice between “continuing TRT” and “treating urinary symptoms.” In many cases, those are separate clinical questions that can be evaluated together.

A man should also understand the limits of the procedure before deciding. PAE results develop gradually, and some patients may not achieve sufficient symptom relief or may eventually need further treatment. Those trade-offs are a normal part of informed decision-making—not a reason to dismiss a minimally invasive option when it is otherwise a strong fit.

Questions Men on Testosterone Therapy Can Ask About PAE

The most useful consultation is one that addresses both urinary relief and whole-person goals. The following questions can help guide the discussion.

A Minimally Invasive Path Forward for BPH Symptoms in Orange County

For men on TRT, new or worsening urinary symptoms do not automatically mean that testosterone therapy is the problem—or that invasive surgery is the only answer. When BPH is contributing to LUTS, prostatic artery embolization may offer a practical, outpatient treatment option that treats the prostate directly while respecting a patient’s priorities around recovery and sexual health.

If frequent urination, nighttime trips to the bathroom, urgency, or a weak stream are getting in the way of your day, schedule a discussion with the team at Vascular and Interventional Specialists of Orange County. We can help determine whether PAE is an appropriate option and how it fits into a coordinated plan with your existing care team.